Common brain cancer mutation changes DNA shape to drive progression, exposing therapeutic target. A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common genetic alterations in glioma rewires the cancer cell genome to fuel tumor progression, suggesting a potential new therapeutic strategy for patients with ATRX-mutant gliomas.
A apuração publicada por medicalxpress.com vira base para uma leitura editorial direta e contextualizada.
Trechos de apoio da pauta: A new study from researchers at The University of Texas MD Anderson Cancer Center has uncovered how one of the most common genetic alterations in glioma rewires the cancer cell genome to fuel tumor progression, suggesting a potential new therapeutic strategy for patients with ATRX-mutant gliomas.
- Ponto de atenção: common.
- Ponto de atenção: brain.
- Ponto de atenção: cancer.
Em resumo, a leitura editorial acompanha o impacto do tema no nicho Fitness.